Q3 2024 Financial Supplement
Financial Supplement
As at
Accounting Changes and Disclosure Matters
(Unaudited)
Page 1
- The current supplementary financial information is following the adoption of IFRS 17 and IFRS 9(1)
-
- Figures reflect both IFRS 17 and IFRS 9 metrics, as well as IFRS 4 metrics where the calculation has been impacted by the adoption of IFRS 17 and/or IFRS 9
- IFRS 17 became effective on
January 1, 2023 , with a transition date ofJanuary 1, 2022 -
- Applied using a full retrospective approach, recognizing any difference in equity
- Figures reflect IFRS 17 (Q1, Q2, Q3 & Q4 2022 restated)
- IFRS 9 became effective for insurance entities on
January 1, 2023 and the Company has elected not to restate comparative periods -
- Q1, Q2 & Q3 2024, Q1, Q2, Q3 & Q4 2023 figures reflect IFRS 9
Index
(Unaudited)
Page 2
1 - Notes to the Financial Supplement
- Important Notes
- Important Definitions
2 - Financial Highlights
- Financial Results
- Underwriting Results
- ROE and Book Value
- Capitalization
3 - Shareholder Information
- Shares Outstanding/Traded
- Common Share Performance
- Ratings
4 - Comprehensive Income & Loss
4.1 Comprehensive Income and Loss
5 - Segmented Underwriting & Performance
- Trisura Specialty(1)
- Trisura Specialty
- Surety
- Warranty
- Canadian Fronting
Corporate Insurance
3-5
6-7
7-8
8
9
9
10 - 12
11-13
6 - Segmented Underwriting & Performance |
13 |
||
- Trisura US Programs (1) |
|||
6.1 |
Trisura US Programs |
||
7 |
- Corporate and Other |
14 |
|
7.1 |
Corporate and Other |
||
8 |
- Segmented Highlights |
15 |
- Insurance Revenue By Business Line
- Book Value
9 - Financial Position |
16 |
|
9.1 |
Statements of Financial Position |
|
9.2 |
Capital Ratios |
|
10 - Investment Portfolio |
17 |
|
10.1 |
Total Portfolio |
|
10.2 |
Fixed Income Credit Quality |
|
10.3 |
Fixed Income Maturity Schedule |
|
19 |
- During Q2, 2024 the business segments were renamed "Trisura Specialty" (formerly "Trisura Canada") and "Trisura US Programs" (formerly "Trisura US"). The composition of the segments has been unaffected by this change.
1.1 - Important Notes
(Unaudited)
Page 3
Important Notes
Please note these statements are unaudited. For additional information, please refer to our MD&A and Consolidated Financial Statements. Financial reports are reported under International Financial Reporting Standards (IFRS). We use both IFRS and non-IFRS measures to assess performance. Non-IFRS measures do not have any standardized meanings prescribed by IFRS and are unlikely to be comparable to any similar measures presented by other companies.
This Financial Supplement contains "forward-looking information" within the meaning of Canadian provincial securities laws and "forward-looking statements" within the meaning of applicable Canadian securities legislation. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, operations, business, financial condition, expected financial results, performance, prospects, opportunities, priorities, targets, goals, ongoing objectives, strategies and outlook of our Company and its subsidiaries, as well as the outlook for North American and international economies for the current fiscal year and subsequent periods, and include words such as "expects," "likely," "anticipates," "plans," "believes," "estimates," "seeks," "intends," "targets," "projects," "forecasts" ", "potential" or negative versions thereof and other similar expressions, or future or conditional verbs such as "may," "will," "should," "would" and "could".
Although we believe that our anticipated future results, performance or achievements expressed or implied by the forward-looking statements and information are based upon reasonable assumptions and expectations, the reader should not place undue reliance on forward-looking statements and information because they involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, which may cause the actual results, performance or achievements of our Company to differ materially from anticipated future results, performance or achievement expressed or implied by such forward-looking statements and information.
Factors that could cause actual results to differ materially from those contemplated or implied by forward-looking statements include, but are not limited to: the impact or unanticipated impact of general economic, political and market factors in the countries in which we do business; the behaviour of financial markets, including fluctuations in interest and foreign exchange rates; global equity and capital markets and the availability of equity and debt financing and refinancing within these markets; insurance risks including pricing risk, concentration risk and exposure to large losses, and risks associated with estimates of loss reserves; strategic actions including dispositions; the ability to complete and effectively integrate acquisitions into existing operations and the ability to attain expected benefits; changes in accounting policies and methods used to report financial condition (including uncertainties associated with critical accounting assumptions and estimates); the ability to appropriately manage human capital; the effect of applying future accounting changes; business competition; operational and reputational risks; technological change; changes in government regulation and legislation within the countries in which we operate; governmental investigations; litigation; changes in tax laws; changes in capital requirements; changes in reinsurance arrangements and availability and cost of reinsurance; ability to collect amounts owed; catastrophic events, such as earthquakes, hurricanes or pandemics; the possible impact of international conflicts and other developments including terrorist acts and cyberterrorism; risks associated with reliance on distribution partners, capacity providers and program administrators; third party risks; risk that models used to manage the business do not function as expected; climate change risk; risk of economic downturn; risk of inflation and other risks and factors detailed from time to time in our documents filed with securities regulators in
We caution that the foregoing list of important factors that may affect future results is not exhaustive. When relying on our forward-looking statements and information, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Except as required by law, our Company undertakes no obligation to publicly update or revise any forward-looking statements or information, whether written or oral, that may be as a result of new information, future events or otherwise.
1.2 - Important Definitions
(Unaudited) |
Page 4 |
Term |
Definition and Usefulness |
|
Book Value per Share |
• |
Shareholders' equity, divided by total number of shares outstanding. Used to calculate theper-sharevalue of a company based on equity |
available to common shareholders. |
||
Ceded Premiums Written |
• |
Premiums ceded to reinsurers in the period. Used by Management for internal measurement, budgeting and forecasting purposes. |
Management views the figure to be useful forward-looking information to measure growth and profitability. |
||
Combined Ratio |
• |
The sum of the loss ratio and the expense ratio. The difference between 100% and the combined ratio represents underwriting income as a |
percentage of Net Premiums Earned ("NPE"), or underwriting margin. A combined ratio under 100% indicates a profitable underwriting result. A |
||
combined ratio over 100% indicates an unprofitable underwriting result. A measure to evaluate pre-tax underwriting profitability. |
||
Debt-to-Capital Ratio |
• |
Total Debt outstanding at the end of the reporting period, divided by sum of: Debt outstanding balance and Shareholders' equity. |
Expense Ratio |
• |
Insurance service expense plus Other operating expenses (net of Other income, which reflects surety fee income, in our Canadian operations) |
as a percentage of NPE. A measure to evaluate pre-tax underwriting profitability. |
||
Fee Income |
• |
A portion of Net income or expense from reinsurance contracts assets, which reflects fees received from reinsurers paid in exchange for |
fronting services. A measure used to evaluate profitability. |
||
Fees as a Percentage of Ceded |
• |
Fee income, adjusted to reflect the portion of fee income bound in a period, rather than recognized as revenue in a period, divided by Ceded |
Premium |
Premiums Written excluding certainnon-recurringitems. Illustrates the rate of fee income generated from ceded premium, and can supplement |
|
measurements of pre-tax underwriting profitability. |
||
Fronting Operational Ratio |
• |
The sum of net claims and loss adjustment expenses, net commissions and operating expenses divided by the sum of NPE and fronting fees. |
A measure of pre-tax underwriting profitability. |
||
Gross Premium Written |
• |
Insurance revenue, adjusted to reflect insurance revenue bound in the period inclusive of any portion of that premium not yet recognized as |
revenue. Used by Management for internal measurement, budgeting and forecasting purposes. Management views the figure to be useful |
||
forward-looking information to measure growth. |
||
Loss Ratio |
• |
Net claims expense as a percentage of NPE. A measure of claims used to evaluate pre-tax underwriting profitability. |
1.2 - Important Definitions (continued)
(Unaudited) |
Page 5 |
Term |
Definition and Usefulness |
|||
Minimum Capital Test ("MCT") |
• |
Our regulated Canadian operations report the results of its MCT as prescribed by the Office of the Superintendent |
||
|
||||
restated or supplemented from time to time. MCT determines the supervisory regulatory capital levels required by our regulated Canadian |
||||
operations. |
||||
Net Claims Expense |
• |
The portion of Insurance service expenses related to movement in the Liability for Incurred claims, less the portion of Net expense from |
||
reinsurance contracts assets related to the Asset for incurred claims, plus the finance (expense) income from insurance and reinsurance |
||||
contracts. A measure of pre-tax underwriting profitability. |
||||
Net Premiums Earned |
• |
The sum of Net Premiums Written and an adjustment to reflect the portion of Net Premiums Written that has been recognized as revenue in a |
||
given period. Used by Management for internal measurement, budgeting and forecasting purposes. Management views the figure to be useful |
||||
to measure growth and profitability. |
||||
Net Premiums Written |
• |
The difference of Gross Written Premium less Ceded Premiums Written. Used by Management for internal measurement, budgeting and |
||
forecasting purposes. Management views the figure to be useful forward-looking information to measure growth and profitability. |
||||
Net Underwriting Revenue |
• |
The sum of net premiums earned and fee income. A measure used in calculating Net underwriting income. |
||
Net Underwriting Income |
• |
Net Premiums Earned, less Insurance service expense, expense from reinsurance contracts assets, and Other operating expenses, plus Other |
||
income and Finance income (expense) from insurance or reinsurance contracts. A measure ofpre-taxunderwriting profitability. |
||||
Operating Net Income |
• |
Net income, adjusted to remove impact of certain items to normalize earnings in order to reflect our North American specialty operations, which |
||
are considered core operations. Items which are not core to operations include Net gains (loss), ECL, the impact of movement in the yield curve |
||||
included in Finance income (expense) from insurance/reinsurance contracts, and Net loss (gain) from life annuity. Adjustments also include |
||||
items which may not be recurring, such as the write-down of reinsurance recoverables, loss from run-off programs, loss on sale of structured |
||||
insurance assets, and certain tax adjustments. Adjustments also include SBC. A measure ofafter-taxprofitability, used in calculating Operating |
||||
EPS and Operating ROE. |
||||
Operating Net Underwriting |
• |
Net underwriting income, incorporating the adjustments to Operating net income, which impact the Net underwriting income, in order to reflect |
||
Income |
our core operations. A measure of pre-tax underwriting profitability. |
|||
Operating Retuon Equity |
• |
ROE calculated using Operating net income for the twelve-month period preceding the reporting date. An alternate measure ofafter-tax |
||
profitability, adjusted for certain items to normalize earnings to core operations in order to better reflect our North American operations. |
||||
Premiums to Capital |
• |
Gross premiums written generated during a given period, annualized, and divided by Trisura US Program's end of period shareholders' equity. |
||
( |
A measure used to evaluate operational leverage. |
|||
Retuon Equity |
• |
Net income for the twelve-month period preceding the reporting date, divided by the average common shareholders' equity over the same |
||
(Last Twelve Months) |
period, adjusted for significant capital transactions, if appropriate. A historical measure ofafter-taxprofitability. |
|||
Other Non-Operating Income |
• |
Income or expenses which are not core to operations. A measure used in calculating Operating net income. |
||
(Expense) |
||||
2 - Financial Highlights
(Unaudited) |
Page 6 |
||||||||||||||||||||||
2 - Financial Highlights |
2024 |
2023 |
2022 |
2024 |
2023 |
2023 |
2022 |
||||||||||||||||
(in 000s of CAD, except otherwise noted) |
Q3 |
Q2 |
Q1 |
Q4 |
Q3 |
Q2 |
Q1 |
Q4 |
Q3 |
Q2 |
Q3 YTD |
Q3 YTD |
Annual |
Annual |
|||||||||
2.1 - Financial Results |
|||||||||||||||||||||||
Gross Premiums Written(1) |
767,756 |
956,118 |
723,014 |
739,195 |
769,944 |
801,756 |
660,456 |
664,802 |
644,820 |
642,215 |
2,446,888 |
2,232,156 |
2,971,351 |
2,433,217 |
|||||||||
Change Y/Y |
(0.3%) |
19.3% |
9.5% |
11.2% |
19.4% |
24.8% |
37.2% |
37.2% |
59.3% |
76.7% |
9.6% |
26.2% |
22.1% |
55.7% |
|||||||||
Net Premiums Written(1) |
205.703 |
230,265 |
161,757 |
173,194 |
173,155 |
137,818 |
113,064 |
137,594 |
106,414 |
145,933 |
597,725 |
424,037 |
597,231 |
498,111 |
|||||||||
Net Premiums Earned(1) |
185,459 |
163,296 |
149,493 |
140,849 |
152,718 |
155,911 |
138,097 |
115,605 |
111,996 |
102,671 |
498,248 |
446,726 |
587,575 |
418,621 |
|||||||||
Operating Net Underwriting Income(Loss) - Trisura Specialty |
19,180 |
14,380 |
18,937 |
18,182 |
22,176 |
16,045 |
18,570 |
13,872 |
15,156 |
14,467 |
52,496 |
56,790 |
74,972 |
59,089 |
|||||||||
Operating Net Underwriting Income(Loss) - Trisura US Programs |
9,786 |
11,031 |
10,423 |
(174) |
8,825 |
8,170 |
9,939 |
8,853 |
7,129 |
7,455 |
31,239 |
26,935 |
26,761 |
32,525 |
|||||||||
Operating Net Underwriting Income(Loss) |
28,966 |
25,411 |
29,360 |
18,008 |
31,001 |
24,215 |
28,509 |
22,725 |
22,285 |
21,922 |
83,735 |
83,725 |
101,733 |
91,614 |
|||||||||
Net Investment Income |
16,252 |
16,902 |
16,753 |
16,206 |
13,493 |
11,899 |
10,071 |
9,479 |
6,583 |
5,077 |
49,907 |
35,463 |
51,669 |
25,162 |
|||||||||
Other Finance Costs |
(998) |
(711) |
(614) |
(565) |
(643) |
(601) |
(600) |
(588) |
(823) |
(642) |
(2,323) |
(1,844) |
(2,409) |
(2,644) |
|||||||||
Adjusted Other Operating Expenses |
(523) |
(585) |
(1,236) |
(269) |
(1,175) |
(1,091) |
(727) |
(177) |
(828) |
(556) |
(2,343) |
(2,993) |
(3,262) |
(2,394) |
|||||||||
Pre-tax Operating Income |
43,697 |
41,018 |
44,263 |
33,380 |
42,676 |
34,421 |
37,253 |
31,439 |
27,217 |
25,802 |
128,978 |
114,351 |
147,730 |
111,738 |
|||||||||
Operating Income Tax Benefit (Expense) |
(10,469) |
(9,765) |
(11,075) |
(7,505) |
(10,952) |
(8,390) |
(8,640) |
(7,920) |
(6,101) |
(6,731) |
(31,309) |
(27,982) |
(35,487) |
(27,375) |
|||||||||
Operating Net Income(2) |
33,228 |
31,253 |
33,188 |
25,875 |
31,724 |
26,032 |
28,613 |
23,519 |
21,116 |
19,071 |
97,669 |
86,369 |
112,244 |
84,363 |
|||||||||
Non-operating Results |
2,860 |
(4,112) |
3,245 |
(14,555) |
(16,886) |
775 |
(14,637) |
(64,229) |
3,108 |
1,872 |
1,993 |
(30,748) |
(45,303) |
(56,568) |
|||||||||
Net Income |
36,088 |
27,141 |
36,433 |
11,320 |
14,838 |
26,807 |
13,976 |
(40,710) |
24,224 |
20,943 |
99,662 |
55,621 |
66,941 |
27,795 |
|||||||||
Insurance Revenue |
807,645 |
772,249 |
744,266 |
754,953 |
730,714 |
664,420 |
639,100 |
595,742 |
550,861 |
464,643 |
2,324,160 |
2,034,234 |
2,789,187 |
2,014,915 |
|||||||||
Change Y/Y |
10.5% |
16.2% |
16.5% |
26.7% |
32.7% |
43.0% |
58.3% |
14.3% |
43.3% |
38.4% |
|||||||||||||
Insurance Service Expenses |
(702,514) |
(582,657) |
(580,940) |
(615,167) |
(562,419) |
(567,217) |
(500,443) |
(474,120) |
(547,859) |
(407,172) |
(1,866,111) |
(1,630,079) |
(2,245,246) |
(1,742,601) |
|||||||||
Net Expense and Income From Reinsurance Contracts Assets |
(69,539) |
(158,187) |
(127,878) |
(135,627) |
(143,546) |
(57,491) |
(121,942) |
(175,384) |
25,588 |
(30,019) |
(355,604) |
(322,979) |
(458,606) |
(243,128) |
|||||||||
Insurance Service Result |
35,592 |
31,405 |
35,448 |
4,159 |
24,749 |
39,712 |
16,715 |
(53,762) |
28,590 |
27,452 |
102,445 |
81,176 |
85,335 |
29,186 |
|||||||||
Total Investment Income |
27,307 |
17,214 |
27,199 |
25,264 |
4,527 |
5,408 |
7,707 |
13,591 |
10,306 |
6,518 |
71,720 |
17,642 |
42,906 |
33,964 |
|||||||||
Net Insurance Finance Expenses and Income |
(4,226) |
(1,599) |
(3,858) |
(4,205) |
(898) |
(287) |
(4,726) |
(400) |
281 |
1,179 |
(9,683) |
(5,911) |
(10,116) |
1,817 |
|||||||||
|
58,673 |
47,020 |
58,789 |
25,218 |
28,378 |
44,833 |
19,696 |
(40,571) |
39,177 |
35,149 |
164,482 |
92,907 |
118,125 |
64,967 |
|||||||||
Net Income and Loss |
36,088 |
27,141 |
36,433 |
11,320 |
14,838 |
26,807 |
13,976 |
(40,710) |
24,224 |
20,943 |
99,662 |
55,621 |
66,941 |
27,795 |
|||||||||
Comprehensive Income and Loss |
50,428 |
30,511 |
45,372 |
19,772 |
16,664 |
16,936 |
19,897 |
(44,663) |
23,927 |
(1,460) |
126,311 |
53,497 |
73,269 |
(19,912) |
|||||||||
Net Income and Loss Per Share (Basic) ($ per share) |
0.76 |
0.57 |
0.77 |
0.24 |
0.32 |
0.58 |
0.30 |
(0.89) |
0.54 |
0.51 |
2.09 |
1.20 |
1.44 |
0.64 |
|||||||||
Net Income and Loss Per Share (Diluted) ($ per share) |
0.74 |
0.56 |
0.75 |
0.23 |
0.31 |
0.57 |
0.30 |
(0.87) |
0.53 |
0.50 |
2.05 |
1.18 |
1.42 |
0.63 |
|||||||||
Operating Net Income Per Share (Basic) ($ per share)(2)(3) |
0.70 |
0.66 |
0.70 |
0.54 |
0.68 |
0.57 |
0.58 |
0.51 |
0.47 |
0.46 |
2.05 |
1.83 |
2.37 |
1.92 |
|||||||||
Operating Net Income Per Share (Diluted) ($ per share)(2)(3) |
0.68 |
0.65 |
0.68 |
0.54 |
0.67 |
0.56 |
0.57 |
0.50 |
0.46 |
0.45 |
2.01 |
1.80 |
2.34 |
1.88 |
|||||||||
|
(11,379) |
(462) |
(12,276) |
(8,132) |
8,708 |
6,867 |
2,215 |
(4,112) |
(3,723) |
(1,441) |
(24,117) |
17,790 |
9,658 |
(8,802) |
|||||||||
Movement in Yield Curve(4) |
2,061 |
(23) |
(436) |
2,071 |
(1,204) |
(2,314) |
4,726 |
255 |
(421) |
(1,316) |
1,602 |
1,208 |
3,279 |
(2,239) |
|||||||||
Non-recurring Items(5) |
4,226 |
3,874 |
3,714 |
23,744 |
15,375 |
(6,629) |
14,691 |
81,473 |
- |
- |
11,814 |
23,437 |
47,181 |
81,550 |
|||||||||
Net Credit Impairment Losses |
324 |
150 |
1,830 |
(926) |
258 |
(376) |
149 |
- |
- |
- |
2,304 |
31 |
(895) |
- |
|||||||||
Impact of SBC |
1,030 |
393 |
2,923 |
1,589 |
(1,949) |
1,815 |
(3,370) |
3,991 |
441 |
194 |
4,346 |
(3,504) |
(1,915) |
1,484 |
|||||||||
Tax Impact of Above Items |
878 |
180 |
1,000 |
(3,791) |
(4,302) |
(138) |
(3,774) |
(17,378) |
595 |
691 |
2,057 |
(8,214) |
(12,005) |
(15,425) |
|||||||||
Non-operating Results |
(2,860) |
4,112 |
(3,245) |
14,555 |
16,886 |
(775) |
14,637 |
64,229 |
(3,108) |
(1,872) |
(1,993) |
30,748 |
45,303 |
56,568 |
|||||||||
2.2 - Underwriting Results |
|||||||||||||||||||||||
Trisura Specialty |
|||||||||||||||||||||||
Loss Ratio(3) |
18.9% |
19.6% |
15.6% |
20.6% |
10.4% |
18.7% |
14.6% |
19.8% |
16.2% |
14.1% |
18.1% |
14.4% |
16.1% |
16.3% |
|||||||||
Combined Ratio(3) |
85.6% |
89.8% |
81.8% |
85.8% |
75.0% |
82.9% |
80.7% |
83.4% |
81.8% |
79.9% |
85.8% |
79.3% |
81.1% |
80.7% |
|||||||||
Trisura US Programs |
|||||||||||||||||||||||
Loss Ratio |
86.0% |
67.7% |
71.9% |
202.7% |
103.6% |
52.5% |
86.3% |
75.4% |
73.2% |
71.9% |
75.7% |
78.2% |
99.6% |
71.4% |
|||||||||
Operating Loss Ratio(3)(6) |
75.1% |
66.7% |
67.1% |
123.0% |
70.7% |
70.9% |
70.7% |
74.4% |
73.6% |
73.0% |
69.9% |
70.8% |
87.6% |
72.2% |
|||||||||
Fronting Operational Ratio(3) |
95.0% |
85.5% |
89.6% |
143.0% |
117.2% |
78.6% |
111.1% |
242.8% |
83.9% |
81.2% |
90.2% |
101.0% |
109.6% |
128.3% |
|||||||||
Operating Fronting Operational Ratio(3)(6) |
87.4% |
84.6% |
84.9% |
100.4% |
86.0% |
83.1% |
82.9% |
82.6% |
84.1% |
81.8% |
85.7% |
84.2% |
90.2% |
81.0% |
- This is a non-IFRS financial measure. See Section 10, Non-IFRS Financial Measures and Other Financial Measures for details on composition and an explanation of how it provides useful information to an investor. (2) Operating Net Income includes the portion of finance income/expense relating to the change in yield curve. (3) This is a non-IFRS ratio. See Section 10, Non-IFRS Financial Measures and Other Financial Measures for details on composition, as well as each non-IFRS financial measure used as a component of this ratio, and an explanation of how it provides useful information to an investor. (4) Impact of movement in yield curve within Finance expenses (income) from insurance and reinsurance contracts. (5) Non-recurring items are items not expected to reoccur in the long term course of business, such as the write-down of reinsurance recoverables, loss from run-off programs, loss on sale of structured insurance assets, and Net loss (gain) from life annuity.(6) These metrics exclude the impact of the 2023 run-off and the Q4 2022 write down on reinsurance recoverables to better reflect our US operations.
2 - Financial Highlights
(Unaudited) |
Page 7 |
|||||||||||||||||||||
2 - Financial Highlights |
2024 |
2023 |
2022 |
2024 |
2023 |
2023 |
2022 |
|||||||||||||||
(in 000s of CAD, except otherwise noted) |
Q3 |
Q2 |
Q1 |
Q4 |
Q3 |
Q2 |
Q1 |
Q4 |
Q3 |
Q2 |
Q3 YTD |
Q3 YTD |
Annual |
Annual |
||||||||
2.3 - ROE and Book Value |
||||||||||||||||||||||
Consolidated |
||||||||||||||||||||||
Retuon Equity (Last Twelve Months)(1)(2) |
16.7% |
14.4% |
15.3% |
12.2% |
2.8% |
4.9% |
4.1% |
6.5% |
19.9% |
19.2% |
16.7% |
2.8% |
12.2% |
6.5% |
||||||||
Operating Retuon Equity (Last Twelve Months)(1)(2) |
||||||||||||||||||||||
18.6% |
19.6% |
20.0% |
20.0% |
20.2% |
19.2% |
20.6% |
19.6% |
N/A |
N/A |
18.6% |
20.2% |
20.0% |
19.6% |
|||||||||
Book Value |
||||||||||||||||||||||
747,381 |
695,186 |
662,214 |
619,429 |
598,686 |
529,680 |
512,458 |
493,651 |
537,028 |
367,002 |
747,381 |
598,686 |
619,429 |
493,651 |
|||||||||
Book Value Per Share(3) |
||||||||||||||||||||||
15.64 |
14.56 |
13.89 |
13.02 |
12.58 |
11.53 |
11.15 |
10.76 |
11.71 |
8.87 |
15.64 |
12.58 |
13.02 |
10.76 |
|||||||||
Trisura Specialty |
||||||||||||||||||||||
Retuon Equity (Last Twelve Months) |
26.5% |
28.4% |
28.8% |
29.1% |
28.8% |
26.7% |
28.4% |
29.8% |
30.6% |
31.6% |
26.5% |
28.8% |
29.1% |
29.8% |
||||||||
Operating Retuon Equity (Last Twelve Months) |
||||||||||||||||||||||
24.9% |
27.5% |
28.1% |
29.2% |
29.7% |
28.4% |
28.2% |
27.8% |
N/A |
N/A |
24.9% |
29.7% |
29.2% |
27.8% |
|||||||||
Book Value |
||||||||||||||||||||||
463,137 |
427,214 |
333,674 |
289,784 |
261,096 |
240,846 |
229,711 |
210,864 |
196,547 |
188,644 |
463,137 |
261,096 |
289,784 |
210,864 |
|||||||||
Book Value Per Share |
9.69 |
8.95 |
7.00 |
6.09 |
5.49 |
5.24 |
5.00 |
4.60 |
4.28 |
4.56 |
9.69 |
5.49 |
6.09 |
4.60 |
||||||||
Trisura US Programs |
||||||||||||||||||||||
Retuon Equity (Last Twelve Months) |
9.1% |
2.5% |
4.1% |
(1.0)% |
(18.2)% |
(12.8)% |
(16.0)% |
(12.1)% |
13.6% |
13.9% |
9.1% |
(18.2)% |
(1.0)% |
(12.1)% |
||||||||
Operating Retuon Equity (Last Twelve Months) |
||||||||||||||||||||||
15.0% |
14.9% |
14.3% |
13.6% |
15.2% |
14.3% |
13.6% |
13.4% |
N/A |
N/A |
15.0% |
15.2% |
13.6% |
13.4% |
|||||||||
Book Value |
||||||||||||||||||||||
318,865 |
302,711 |
289,779 |
270,207 |
279,180 |
279,276 |
269,807 |
241,557 |
264,018 |
248,097 |
318,865 |
279,180 |
270,207 |
241,557 |
|||||||||
Book Value Per Share |
6.67 |
6.34 |
6.08 |
5.68 |
5.87 |
6.08 |
5.87 |
5.26 |
5.76 |
6.00 |
6.67 |
5.87 |
5.68 |
5.26 |
||||||||
2.4 - Capitalization |
||||||||||||||||||||||
Debt-to-Capital Ratio(1) |
11.6 % |
12.4 % |
10.2 % |
10.8 % |
11.1 % |
12.4 % |
12.8 % |
13.2 % |
12.3 % |
22.2 % |
11.6 % |
11.1 % |
10.8 % |
13.2 % |
||||||||
MCT Ratio ( |
263 % |
267 % |
259 % |
251 % |
246 % |
224 % |
240 % |
N/A |
N/A |
N/A |
263 % |
246 % |
251 % |
N/A |
||||||||
Premiums to Capital - US(3) |
5.6 |
x |
7.6 |
x |
6.2 x |
6.1 |
x |
6.8 |
x |
7.2 x |
6.4 x |
6.5 |
x |
7.1 x |
7.2 x |
6.2 |
x |
6.7 x |
6.7 |
x |
6.2 |
x |
- This is a non-IFRS ratio. See Section 10, Non-IFRS Financial Measures and Other Financial Measures for details on composition, as well as each non-IFRS financial measure used as a component of this ratio, and an explanation of how it provides useful information to an investor. (2) Q1, Q2 and Q3 2022 balances for ROE and Operating ROE have not been restated to conform with adoption of new accounting standards as it is not feasible to do so. (3) This is a supplementary financial measure. See Section 10, Operating Metrics or slide 1.2, Important Definitions for additional detail. This includes
25 million USD surplus note in Trisura US Programs. (4) This measure is calculated in accordance with theOffice of OSFI's Guideline A , Minimum Capital Test.
3 - Shareholder Information
(Unaudited) |
Page 8 |
|||||||||||||
3 - Shareholder Information |
2024 |
2023 |
2022 |
2024 |
2023 |
2023 |
2022 |
|||||||
(in 000s of CAD, except otherwise noted) |
Q3 |
Q2 |
Q1 |
Q4 |
Q3 |
Q2 |
Q1 |
Q4 |
Q3 |
Q2 |
Q3 YTD |
Q3 YTD |
Annual |
Annual |
3.1 - Shares Outstanding/Traded |
||||||||||||||
End of Period (000s of shares) |
47,779 |
47,746 |
47,673 |
47,579 |
47,579 |
45,959 |
45,959 |
45,881 |
45,871 |
41,359 |
47,779 |
47,579 |
47,579 |
45,881 |
Weighted Average (000s of shares) |
47,755 |
47,697 |
47,596 |
47,579 |
46,671 |
45,959 |
45,997 |
45,874 |
45,226 |
41,278 |
47,683 |
46,174 |
46,529 |
43,416 |
Average Daily Volume Traded at Quarter End (30 Day, # of Shares) |
147,592 |
123,096 |
130,620 |
139,551 |
233,838 |
158,537 |
261,436 |
159,391 |
108,146 |
120,654 |
147,592 |
233,838 |
196,155 |
159,391 |
3.2 - Common Share Performance |
Common Share Price at Quarter End ($ per share) Change Q/Q and Y/Y
Period Low ($ per share)
Volume-Weighted Average Price ($ per share) Change Q/Q
Market Capitalization at Quarter End
Change Q/Q and Y/Y
3.3 - Ratings
43.19 |
41.38 |
41.65 |
34.00 |
30.13 |
37.57 |
33.09 |
45.29 |
33.41 |
33.33 |
43.19 |
30.13 |
34.00 |
45.29 |
4.4% |
(0.6%) |
22.5% |
12.8% |
(19.8%) |
13.5% |
(26.9%) |
35.6% |
0.2% |
(3.0%) |
43.3% |
(9.8%) |
(24.9%) |
(5.0%) |
46.38 |
45.37 |
44.20 |
34.65 |
37.93 |
38.37 |
46.17 |
47.17 |
41.60 |
36.22 |
46.38 |
46.17 |
46.17 |
48.05 |
39.27 |
40.19 |
33.30 |
29.34 |
30.13 |
29.58 |
30.93 |
33.73 |
30.83 |
29.77 |
33.30 |
29.58 |
29.34 |
29.28 |
41.92 |
42.38 |
38.90 |
31.98 |
33.38 |
34.51 |
37.82 |
42.41 |
35.69 |
33.31 |
||||
(1.1%) |
8.9% |
21.7% |
(4.2%) |
(3.3%) |
(8.8%) |
(10.8%) |
18.8% |
7.2% |
(12.3%) |
||||
2,063,575 |
1,975,729 |
1,985,580 |
1,617,686 |
1,433,555 |
1,726,680 |
1,520,784 |
2,077,961 |
1,532,545 |
1,378,490 |
2,063,575 |
1,433,555 |
1,617,686 |
2,077,961 |
4.4% |
(0.5%) |
22.7% |
12.8% |
(17.0%) |
13.5% |
(26.8%) |
35.6% |
11.2% |
(2.8%) |
43.9% |
(6.5%) |
(22.2%) |
5.7% |
Financial strength ratings - principal Canadian operating subsidiary A.M. Best Rating (Since 2012)
DBRS
Financial strength ratings - principal US operating subsidiary A.M. Best Rating (Since 2017)
DBRS
Senior Unsecured Notes rating -
DBRS
(Excellent) |
A- (Excellent) A- (Excellent) |
(Excellent) |
A- (Excellent) |
(Excellent) |
A- (Excellent) |
(Excellent) |
A- (Excellent) A- (Excellent) |
(Excellent) |
A- (Excellent) |
(Excellent) |
(Excellent) |
||
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
(Excellent) |
A- (Excellent) A- (Excellent) |
(Excellent) |
A- (Excellent) |
(Excellent) |
A- (Excellent) |
(Excellent) |
A- (Excellent) A- (Excellent) |
(Excellent) |
A- (Excellent) |
(Excellent) |
(Excellent) |
||
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
A (low) |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
BBB |
4 - Comprehensive Income and Loss
(Unaudited) |
Page 9 |
|||||||||||||||||||||
4 - Comprehensive Income and Loss |
2024 |
2023 |
2022 |
2024 |
2023 |
2023 |
2022 |
|||||||||||||||
(in 000s of CAD, except otherwise noted) |
Q3 |
Q2 |
Q1 |
Q4 |
Q3 |
Q2 |
Q1 |
Q4 |
Q3 |
Q2 |
Q3 YTD |
Q3 YTD |
Annual |
Annual |
||||||||
4.1 - Comprehensive Income and Loss |
||||||||||||||||||||||
Gross Premiums Written |
767,756 |
956,118 |
723,014 |
739,195 |
769,944 |
801,756 |
660,456 |
664,802 |
644,820 |
642,215 |
2,446,888 |
2,232,156 |
2,971,350 |
2,433,217 |
||||||||
Net Premium Written |
205,703 |
230,265 |
161,757 |
173,194 |
173,155 |
137,818 |
113,064 |
137,594 |
106,414 |
145,933 |
597,725 |
424,037 |
597,231 |
498,111 |
||||||||
Net Premium Earned |
185,459 |
163,296 |
149,493 |
140,849 |
152,718 |
155,911 |
138,097 |
115,605 |
111,996 |
102,671 |
498,248 |
446,726 |
587,575 |
418,621 |
||||||||
Fee Income |
24,277 |
22,905 |
27,475 |
22,926 |
21,604 |
19,810 |
23,174 |
20,124 |
18,855 |
16,311 |
74,657 |
64,588 |
87,514 |
73,517 |
||||||||
Net Underwriting Income |
22,679 |
22,048 |
26,082 |
(7,581) |
16,832 |
33,157 |
9,092 |
(59,004) |
22,706 |
23,239 |
70,809 |
59,081 |
51,500 |
12,379 |
||||||||
Insurance Revenue |
807,645 |
772,249 |
744,266 |
754,953 |
730,714 |
664,420 |
639,100 |
595,742 |
550,861 |
464,643 |
2,324,160 |
2,034,234 |
2,789,187 |
2,014,915 |
||||||||
Insurance Service Expenses |
(702,514) |
(582,657) |
(580,940) |
(615,167) |
(562,419) |
(567,217) |
(500,443) |
(474,120) |
(547,859) |
(407,172) |
(1,866,111) |
(1,630,079) |
(2,245,246) |
(1,742,601) |
||||||||
Net Expense and Income From Reinsurance Contracts Assets |
(69,539) |
(158,187) |
(127,878) |
(135,627) |
(143,546) |
(57,491) |
(121,942) |
(175,384) |
25,588 |
(30,019) |
(355,604) |
(322,979) |
(458,606) |
(243,128) |
||||||||
Insurance Service Result |
35,592 |
31,405 |
35,448 |
4,159 |
24,749 |
39,712 |
16,715 |
(53,762) |
28,590 |
27,452 |
102,445 |
81,176 |
85,335 |
29,186 |
||||||||
Net Investment Income |
16,252 |
16,902 |
16,753 |
16,206 |
13,493 |
11,899 |
10,071 |
9,479 |
6,583 |
5,077 |
49,907 |
35,463 |
51,669 |
25,162 |
||||||||
|
11,379 |
462 |
12,276 |
8,132 |
(8,708) |
(6,867) |
(2,215) |
4,112 |
3,723 |
1,441 |
24,117 |
(17,790) |
(9,658) |
8,802 |
||||||||
Net Credit Impairment Losses and Reversals |
(324) |
(150) |
(1,830) |
926 |
(258) |
376 |
(149) |
- |
- |
- |
(2,304) |
(31) |
895 |
- |
||||||||
Total Investment Income |
27,307 |
17,214 |
27,199 |
25,264 |
4,527 |
5,408 |
7,707 |
13,591 |
10,306 |
6,518 |
71,720 |
17,642 |
42,906 |
33,964 |
||||||||
Finance Income and Expenses From Insurance Contracts |
(29,356) |
(5,493) |
(36,658) |
(27,716) |
(11,521) |
(10) |
(36,628) |
(7,400) |
(622) |
3,782 |
(71,507) |
(48,159) |
(75,875) |
4,582 |
||||||||
Finance Income and Expenses From Reinsurance Contracts |
25,130 |
3,894 |
32,800 |
23,511 |
10,623 |
(277) |
31,902 |
7,000 |
903 |
(2,603) |
61,824 |
42,248 |
65,759 |
(2,765) |
||||||||
Net Insurance Finance Income and Expenses |
(4,226) |
(1,599) |
(3,858) |
(4,205) |
(898) |
(287) |
(4,726) |
(400) |
281 |
1,179 |
(9,683) |
(5,911) |
(10,116) |
1,817 |
||||||||
Net Financial Result |
23,081 |
15,615 |
23,341 |
21,059 |
3,629 |
5,121 |
2,981 |
13,191 |
10,587 |
7,697 |
62,037 |
11,731 |
32,790 |
35,781 |
||||||||
|
58,673 |
47,020 |
58,789 |
25,218 |
28,378 |
44,833 |
19,696 |
(40,571) |
39,177 |
35,149 |
164,482 |
92,907 |
118,125 |
64,967 |
||||||||
Other Income |
816 |
837 |
5,345 |
727 |
847 |
902 |
5,178 |
733 |
663 |
855 |
6,998 |
6,927 |
7,654 |
6,593 |
||||||||
Other Operating Expenses |
(11,056) |
(10,060) |
(15,012) |
(10,346) |
(7,094) |
(10,075) |
(5,432) |
(9,742) |
(8,097) |
(6,997) |
(36,128) |
(22,601) |
(32,947) |
(29,171) |
||||||||
Other Finance Costs |
(998) |
(711) |
(614) |
(565) |
(643) |
(601) |
(600) |
(588) |
(823) |
(642) |
(2,323) |
(1,844) |
(2,409) |
(2,644) |
||||||||
Income and Loss Before Income Taxes |
47,435 |
37,086 |
48,508 |
15,034 |
21,488 |
35,059 |
18,842 |
(50,168) |
30,920 |
28,365 |
133,029 |
75,389 |
90,423 |
39,745 |
||||||||
Income Tax Expense |
(11,347) |
(9,945) |
(12,075) |
(3,714) |
(6,650) |
(8,252) |
(4,866) |
9,458 |
(6,696) |
(7,422) |
(33,367) |
(19,768) |
(23,482) |
(11,950) |
||||||||
Net Income and Loss Attributable to Shareholders |
36,088 |
27,141 |
36,433 |
11,320 |
14,838 |
26,807 |
13,976 |
(40,710) |
24,224 |
20,943 |
99,662 |
55,621 |
66,941 |
27,795 |
||||||||
Other Comprehensive Income and Loss |
14,340 |
3,370 |
8,939 |
8,452 |
1,826 |
(9,871) |
5,921 |
(3,953) |
(297) |
(22,403) |
26,649 |
(2,124) |
6,328 |
(47,707) |
||||||||
Comprehensive Income and Loss |
50,428 |
30,511 |
45,372 |
19,772 |
16,664 |
16,936 |
19,897 |
(44,663) |
23,927 |
(1,460) |
126,311 |
53,497 |
73,269 |
(19,912) |
(1)
Attachments
Disclaimer
Russia Is Running an Undeclared War on Western Shipping
Annual Report by Investment Company Form N CSR
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News